Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
36.36
+2.85 (8.50%)
At close: Aug 14, 2025, 4:00 PM
35.86
-0.50 (-1.38%)
After-hours: Aug 14, 2025, 4:04 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $224.34 million as of August 14, 2025. Its market cap has increased by 1,645.93% in one year.
Market Cap
224.34M
Enterprise Value
161.89M
1-Year Change
1,645.93%
Ranking
Category
Stock Price
$36.36
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $224.34M, a decrease of -18.76%. That is a compound annual growth rate of -3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 204.92M | 52.74% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | 70.09M | -59.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |